Skip to Main Content

Paper Details

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Sci Transl Med
79
2020
Author NameAffiliation
Sophie LeboucherInstitut Curie, PSL Research University
Jos JonkersNetherlands Cancer Institute
Yves PommierCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Yves PommierCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Elisabetta MarangoniInstitut Curie, PSL Research University
  • 1 - 5

Datasets

Release 1.2